Jun 12, 2014

Shareholder Update: June 2014

In this issue:

› VivaGel^® BV prevention of recurrence: start of phase 3 trials close

› R&D tax incentive cash received

› DEP™ docetaxel trial progressing well

› VivaGel^®-coated condom: preparing for launch

› VivaGel^® BV symptomatic relief product: commercial and regulatory progress

› Strong results for dendrimer enhanced agrochemicals

Download: Shareholder Update: June 2014 ( pdf file, 2MB)

 This contains certain forward-looking statements.